GS030-DP, GS030-DP, GS030-DP
GS030_CLIN_001
Phase 2 small_molecule active
Quick answer
GS030-DP, GS030-DP, GS030-DP for Retinitis Pigmentosa is a Phase 2 program (small_molecule) at GenSight Biologics S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GenSight Biologics S.A.
- Indication
- Retinitis Pigmentosa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active